Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step...
Estar Medical is delighted to take part in the TOBI congress - a major yearly event for the international orthobiologics community...
Estar Medical is delighted to take part in the FACE conference and exhibition. UK's premier conference for aesthetic medicine community...
The products shown in this webpage are not cleared by the U.S. FDA for sale in the USA.
© 2020 All rights reserved to Estar Medical UK Ltd.
